Association of inflammatory biomarkers with comorbidity in chronic obstructive pulmonary disease – results from the COSYCONET cohort

F. Seiler (Saarbrücken, Germany)

Source: International Congress 2017 – Current challenges in COPD evaluation
Session: Current challenges in COPD evaluation
Session type: Poster Discussion
Number: 392
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Seiler (Saarbrücken, Germany). Association of inflammatory biomarkers with comorbidity in chronic obstructive pulmonary disease – results from the COSYCONET cohort. 392

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012


The prognostic importance of the protease-antiprotease imbalance in development of chronic obstructive pulmonary disease comorbid with chronic pancreatitis
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015


Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016

Association between chronic obstructive pulmonary disease and endometriosis: a population-based cohort study
Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases
Year: 2020

Cardiovascular comorbidities in chronic obstructive pulmonary disease patients
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Clinical and inflammatory features of exacerbations of occupational chronic obstructive pulmonary disease
Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction
Year: 2017


Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012


Study of inflammatory markers and BODE index in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016


Association between number of steps and mortality in patients with severe chronic obstructive pulmonary disease
Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease
Year: 2017

Biomarkers in the management of COPD
Source: Eur Respir Rev 2009; 18: 96-104
Year: 2009



Association of low income with pulmonary disease progression in smokers with and without chronic obstructive pulmonary disease
Source: ERJ Open Res, 4 (4) 00069-2018; 10.1183/23120541.00069-2018
Year: 2018



Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012


Cardiovascular risk factors in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006

Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020


Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Prevalence of comorbidity in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001

Assessment of the burden of caregiving for patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Pulmonary rehabilitation beyond training
Year: 2007


Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Analysis of mortality in Japanese patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD
Year: 2010

Functional and inflammatory bowel diseases in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019